Kaletra (DOH CENTRAL PHARMACY)


Welcome to the PulseAid listing for the Kaletra drug offered from DOH CENTRAL PHARMACY. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],UDP Glucuronosyltransferases Inducers [MoA],HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: DOH CENTRAL PHARMACY
NON-PROPRIETARY NAME: lopinavir and ritonavir
SUBSTANCE NAME: LOPINAVIR; RITONAVIR
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],UDP Glucuronosyltransferases Inducers [MoA],HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00


Kaletra HUMAN PRESCRIPTION DRUG Details:

Item DescriptionKaletra from DOH CENTRAL PHARMACY
LABELER NAME: DOH CENTRAL PHARMACY
DEA SCHEDULE:
ACTIVE STRENGTH: 200; 50(mg/1; mg/1)
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53808-0276_b4e1380c-7e64-4455-a71f-080954122c0e
PRODUCT NDC: 53808-0276
APPLICATION NUMBER: NDA021906

Other LOPINAVIR; RITONAVIR Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AbbVie Inc.Kaletra
Cardinal HealthKaletra
Dispensing Solutions, Inc.Kaletra
DOH CENTRAL PHARMACYKaletra
HHS/Program Support Center/Supply Service CenterKaletra
Lannett Company, Inc.Lopinavir-Ritonavir
PD-Rx Pharmaceuticals, Inc.Kaletra
Physicians Total Care, Inc.Kaletra
Rebel Distributors CorpKaletra
REMEDYREPACK INC.Kaletra